Name: UMIN ID:
Unique ID issued by UMIN | UMIN000006744 |
---|---|
Receipt number | R000007969 |
Scientific Title | Phase I/II study of bexarotene capsule (BSC-1) in patients with Cutaneous T-cell Lymphoma (CTCL) |
Date of disclosure of the study information | 2011/12/01 |
Last modified on | 2016/04/07 16:28:48 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2011/11/18 14:56:18 | ||
2 | Update | 2011/11/23 12:20:39 | Public title |
|
3 | Update | 2011/11/23 12:42:08 | Last name of contact person Last name of contact person Division name Address Division name Address Organization1 Address1 Tel1 Email1 Date of disclosure of the study information |
|
4 | Update | 2011/11/23 16:37:02 | Key inclusion criteria Key exclusion criteria Key exclusion criteria |
|
5 | Update | 2011/12/01 08:15:51 | Key inclusion criteria Key exclusion criteria |
|
6 | Update | 2011/12/01 20:42:28 | Public title Acronym Acronym |
|
7 | Update | 2011/12/01 21:03:50 | Narrative objectives1 Narrative objectives1 Primary outcomes |
|
8 | Update | 2011/12/01 21:07:07 | Address |
|
9 | Update | 2011/12/01 21:23:30 | Interventions/Control_1 Key inclusion criteria Key inclusion criteria Key exclusion criteria Key exclusion criteria |
|
10 | Update | 2012/05/11 14:44:24 | Recruitment status |
|
11 | Update | 2012/05/11 14:55:29 | Institutions |
|
12 | Update | 2014/06/18 16:29:16 | TEL Email1 |
|
13 | Update | 2014/06/18 17:03:02 | Last follow-up date Date of closure to data entry |
|
14 | Update | 2014/06/18 17:04:43 | Recruitment status |
|
15 | Update | 2016/04/05 13:21:16 | Date trial data considered complete Date analysis concluded |
|
16 | Update | 2016/04/05 13:21:45 | Recruitment status |
|
17 | Update | 2016/04/05 13:24:39 | Name of primary person or sponsor Organization |
|
18 | Update | 2016/04/07 16:15:28 | Randomization Randomization unit Interventions/Control_1 Key inclusion criteria Key exclusion criteria Key exclusion criteria |
|
19 | Update | 2016/04/07 16:28:48 | Key exclusion criteria |